MILLENNIUM MANAGEMENT LLC - CATABASIS PHARMACEUTICALS IN ownership

CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 25 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$66,000
-87.0%
82,765
-84.4%
0.00%
-100.0%
Q2 2018$508,000
+1351.4%
530,187
+3153.9%
0.00%
Q3 2017$35,000
-82.9%
16,294
-36.9%
0.00%
Q4 2015$205,000
-60.3%
25,830
-59.6%
0.00%
-100.0%
Q3 2015$517,000
-43.4%
63,957
-14.5%
0.00%
-50.0%
Q2 2015$913,00074,7910.00%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
SV Health Investors, LLC 2,857,667$10,573,00010.68%
Clarus Ventures, LLC 2,752,488$10,184,0008.91%
Rhenman & Partners Asset Management AB 345,100$1,277,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 203,243$752,0000.20%
Camber Capital Management LP 1,000,000$3,700,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 643,580$2,381,0000.09%
FT Options LLC 15,059$56,0000.05%
FRED ALGER MANAGEMENT, LLC 86,782$321,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 27,700$102,0000.00%
FIRST NEW YORK SECURITIES LLC /NY 750$2,775,0000.00%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders